FrownSeed search

Modernas

Browse 3 FrownSeed articles about Modernas.

3 results

• 
  Moderna's Cancer Vaccine: Assessing Clinical Data Against Market Expectations

  The biotechnology sector has seen significant investor interest in mRNA technology, particularly following its success in addressing the COVID-19 pandemic. This

• 
  Moderna's mRNA Flu Vaccine: What a Potential Market Game-Changer Means for Investors and Public Health

  Moderna, the biotech firm that saw its valuation skyrocket during the pandemic, is now turning its formidable mRNA platform toward its next major target: the se

• 
  Moderna's Next Frontier: mRNA Flu Vaccine Secures FDA Nod, Reshaping a $7 Billion Market

  Moderna has officially secured FDA approval for its mRNA-based flu vaccine, mRESVIA, marking a significant strategic pivot for the biotech giant beyond its COVI